1-3 of 3
Bouchra Badaoui, PharmD
Close
Sort by
Journal Articles

The Absolute Count of Circulating, Classical, CD14 ++ /CD16 - Monocytes Is a Poor Prognosis Marker in Chronic Myelomonocytic Leukemia (CMML)

Matthieu Jestin, Sihem Tarfi, PharmD, Bouchra Badaoui, PharmD, Nicolas Freynet, PharmD, Ivan Sloma, PharmD,PhD, Margot Morabito, Sébastien Maury, MD PhD, Pierre Fenaux, MD PhD, Eric Solary, MD PhD, Dorothée Selimoglu-Buet, PhD, Orianne Wagner Ballon, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4242.
https://doi.org/10.1182/blood-2019-121794
Published: 2019
Journal Articles

Disappearance of Slan-Positive Non-Classical Monocytes As a New Parameter for the Diagnosis of Chronic Myelomonocytic Leukemia with Associated Inflammatory State

Sihem Tarfi, PharmD, Bouchra Badaoui, PharmD, Nicolas Freynet, PharmD, Margot Morabito, Jeffie Lafosse, Andrea Toma, MD PhD, Pierre Fenaux, MD PhD, Eric Solary, MD PhD, Dorothée Selimoglu-Buet, PhD, Orianne Wagner Ballon, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4376.
https://doi.org/10.1182/blood-2018-99-116451
Published: 2018
Journal Articles

Red Blood Cell Lysis Procedure Improves the Performances of ELN Dyserythropoiesis Score Compared to Nuclear Dye Use without Lysis

Hugo Germain, Sihem Tarfi, PharmD, Nicolas Freynet, PharmD, Andrea Toma, MD PhD, Bouchra Badaoui, PharmD, Orianne Wagner Ballon, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3108.
https://doi.org/10.1182/blood-2018-99-114179
Published: 2018